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Nadi T. Wickramasekera, James Wahlberg, and Paula Traktman
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Vaccinia virus, the prototypic poxvirus, efficiently and faithfully replicates its200-kb DNA genome within the cytoplasm of
infected cells. This intracellular localization dictates that vaccinia virus encodes most, if not all, of its own DNA replicationma-
chinery. Included in the repertoire of viral replication proteins is the I3 protein, which binds to single-stranded DNA (ssDNA)
with great specificity and stability and has been presumed to be the replicative ssDNA binding protein (SSB). We substantiate
here that I3 colocalizes with bromodeoxyuridine (BrdU)-labeled nascent viral genomes and that these genomes accumulate in
cytoplasmic factories that are delimited by membranes derived from the endoplasmic reticulum. Moreover, we report on a struc-
ture/function analysis of I3 involving the isolation and characterization of 10 clustered charge-to-alanine mutants. These mu-
tants were analyzed for their biochemical properties (self-interaction and DNA binding) and biological competence. Three of the
mutant proteins, encoded by the I3 alleles I3-4, -5, and -7, were deficient in self-interaction and unable to support virus viability,
strongly suggesting that the multimerization of I3 is biologically significant. Mutant I3-5 was also deficient in DNA binding. Ad-
ditionally, we demonstrate that small interfering RNA (siRNA)-mediated depletion of I3 causes a significant decrease in the ac-
cumulation of progeny genomes and that this reduction diminishes the yield of infectious virus.
Vaccinia virus, the prototypic poxvirus, is a large DNA virusthat replicates exclusively in the cytoplasm. This lack of access
to the DNA replication machinery of the host necessitates that
poxviruses encode the proteins required for faithful and efficient
replication and maturation of their genome (2, 34). A combina-
tion of biochemical, genetic, and genomic approaches has led to
the identification of the viral DNA polymerase (E9), a heterodi-
meric processivity factor (A20 and D4, which is also a uracil DNA
glycosylase [UDG]), the D5 protein (the putative primase/heli-
case), and the I3 single-stranded DNA (ssDNA) binding protein
(SSB) as key proteins that function at the replication fork (3, 10–
12, 14, 21, 25, 33, 40, 42, 47, 53). Additional proteins also support
DNA replication (H5), and yet others are involved in precursor
metabolism (J2 and F4/I4), recombination/repair (G5), matura-
tion (A22), and encapsidation (I6 and A32) of the genome (5, 7,
15, 16, 45). Finally, the B1 protein kinase is required to overcome
the antiviral effects of the host DNA binding protein BAF. BAF
binds to and sequesters the viral DNA, preventing its replication,
unless it is phosphorylated on its N= terminus by B1 (58).
The mode of poxvirus genome replication remains poorly un-
derstood. The genome is an 200-kb linear double-stranded
DNA (dsDNA)duplexwith covalently closed hairpin termini. The
working model of replication (2, 34) posits that replication is ini-
tiated by the introduction of a nick near one of the termini, which
then provides a primer terminus that can be elongated by the
processive viral polymerase. Replication of the terminal loop
could position the polymerase to copy both strands of the genome
in a leading strand-only mode of replication. Such a replication
model would lead to tail-to-tail dimers and higher-order concate-
mers, which have indeed been seen in vivo (2, 35). However, the
recent observation that theD5 protein has primase activity in vitro
(9) suggests that replication might include lagging-strand synthe-
sis, which has not yet been confirmed or excluded. Recombina-
tional priming, which has been seen with some bacteriophages,
may also occur.
Regardless of whether or not replication involves leading-
strand synthesis only, protection of regions of single-stranded
DNA that are exposed during replication would require a replica-
tive SSB. Some years ago, we proposed that the vaccinia virus I3
protein served as the replicative SSB (42). I3 is an abundant 30-
kDa protein (with an electrophoretic mobility of34 kDa) that is
expressed at both early and intermediate times postinfection and
binds tightly and specifically to single-stranded DNA. Subsequent
reports confirmed the DNA binding properties of I3 and sug-
gested that it facilitates both DNA replication and recombination
in vivo (14, 53). However, definitive evidence that I3 is the repli-
cative SSBhas not yet been presented, nor has a structure/function
analysis. The data described in this report address these questions.
We describe the generation and analysis of 10 clustered charge-to-
alanine mutants of I3 and address the ability of the mutant I3
proteins to bind to DNA and tomultimerize in vitro. The proteins
encoded by three of the alleles generated exhibited defects in one
or both of these assays. In addition, we describe the generation of
viruses in which the endogenous wild-type (WT) I3 gene has been
replaced by these mutant alleles and report that the same three
mutant alleles of the I3 gene are unable to support virus viability in
Received 25 January 2012 Accepted 9 March 2012
Published ahead of print 21 March 2012
Address correspondence to Paula Traktman, ptrakt@mcw.edu.
M.D.G. and K.A.B. contributed equally to this article.
Supplemental material for this article may be found at http://jvi.asm.org/.
Copyright © 2012, American Society for Microbiology. All Rights Reserved.
doi:10.1128/JVI.00206-12
June 2012 Volume 86 Number 11 Journal of Virology p. 6197–6209 jvi.asm.org 6197
vivo. Finally, we show that small interfering RNA (siRNA)-medi-
ated depletion of I3 leads to a reduction in the accumulation of
progeny genomes and viral yield. Cumulatively, these data sup-
port the conclusion that I3 is a replicative SSB and shed light on
the biochemical properties of the protein.
MATERIALS AND METHODS
Reagents. Restriction endonucleases, T4 DNA ligase, T4 polynucleotide
kinase (PNK), calf intestinal phosphatase (CIP), pancreatic RNase, PCR-
grade deoxynucleoside triphosphates (dNTPs), Taq DNA polymerase,
and DNAmolecular weight standards were purchased from Roche Diag-
nostics (Indianapolis, IN) and were used per the manufacturer’s specifi-
cations. [35S]methionine and [-32P]ATP were purchased from Perkin
Elmer Life Sciences (Boston, MA). A peptide carrying three copies of a
FLAG tag (3FLAG-peptide) and EZview Red anti-FLAGM2Affinity gel
beads were obtained from Sigma (St. Louis, MO). Lipofectamine 2000,
Geneticin (G418 sulfate) and 14C-labeled proteinmolecular weightmark-
ers were purchased from Invitrogen (Carlsbad, CA). A T7 Coupled Re-
ticulocyte Lysate System for in vitro coupled transcription/translation
(IVTT) was purchased from Promega (Madison, WI). siRNA duplexes
were purchased from Dharmacon RNAi Technologies (Lafayette, CO).
Oligonucleotide primers were purchased from Integrated DNA Technol-
ogies (IDT; Coralville, IA). Protran nitrocellulose was obtained from
Whatman, Inc. (Dassel, Germany).
Cells and virus.Monolayer cultures of African green monkey BSC40
cells were maintained at 37°C in Dulbecco modified eagle medium
(DMEM; Invitrogen) containing 5% fetal calf serum (FCS). Viral stocks
were prepared from cytoplasmic lysates of infected BSC40 cells by ultra-
centrifugation through 36% sucrose; titers were determined by plaque
assays performed on BSC40 cells. For virological studies, 31.5°C and
39.7°C were used as the permissive and nonpermissive temperatures, re-
spectively.
Targetedmutagenesis and cloning of the I3 gene.Ten regions within
the I3 open reading frame (ORF) were chosen for clustered charge-to-
alaninemutagenesis (Fig. 1) (8, 16, 40). An overlap PCR strategy was used
to introduce the targeted mutations using the cloned HindIII I fragment
as a template and the primers listed in Table S1 in the supplemental ma-
terial. Two sequential rounds of PCR were performed to generate prod-
ucts that overlapped by 17 bp. In the first round, two separate reactions
using primers U(x) plus XB and primers XC and D(x) were performed.
Onemicroliter of each of the two reaction products wasmixed and served
as the template for a third PCR, which was performed using the U(x) and
D(x) primers. The final PCR product was glass purified and digested with
BamHI. The pUC-Neo vector (29) was digested with BamHI, treated with
CIP, and ligated to the similarly digested insert. The pUC-Neo vector
contains the neomycin resistance (Neo) gene under the regulation of the
vaccinia virus p7.5 constitutive promoter. All constructs were subjected to
DNA sequencing to confirm the presence of the desiredmutation and the
absence of spurious mutations. TheWT allele and all 10 clustered charge-
to-alanine alleles of the I3 gene were also amplified using the Cloning U
and Cloning D primers; following digestion with NdeI and BamHI, the
inserts were ligated into pTM1-3FLAG and pET14b vectors that had
been similarly digested and treated with CIP. The resultant plasmids en-
code 3FLAG- and His6-tagged versions of each I3 allele.
Transient dominant selection and isolation of I3mutants.Transient
dominant selection was used to replace the endogenous I3 ORF with the
mutant alleles (8, 13, 16, 26, 29, 40). All infections were performed at
31.5°C to ensure that temperature-sensitive (ts) viruses could be isolated.
BSC40 cells in 35-mm dishes were infected withWT virus (multiplicity of
infection [MOI] of 0.03). At 3 h postinfection (hpi), 3.5g of supercoiled
pUC/Neo-I3 DNA was introduced into cells using Lipofectamine 2000
(Invitrogen) per the manufacturer’s recommendations, and cells were
placed at 31.5°C. At 16 hpi, Geneticin (G418 sulfate) was added to a final
concentration of 3 mg per ml to select for viral recombinants. Transfec-
tions were harvested at 48 hpi, and Neor viruses were isolated by two
rounds of plaque purification in the presence of G418. Integration of the
Neo cassette was confirmed by PCR analysis. Further plaque purification
was performed in the absence of drug selection to enable recombinational
resolution of the tandem repeats and subsequent loss of the Neo gene. To
identify the plaques that lost Neo and retained the mutant I3 allele, rather
FIG 1 Alignment of poxviral I3 homologs and identification of residues targeted for mutagenesis. An alignment of the predicted primary amino acid sequence
of the I3 proteins encoded by vaccinia (VACV), variola (VARV), monkeypox (MPXV), camelpox (CMLV), cowpox (CPXV), ectromelia (ECTV), myxoma
(MYX), swinepox (SWPV), lumpy skin disease (LSDV), sheeppox (SPPV), and molluscum contagiosum (MOCV) viruses (the sequences were obtained from
www.poxvirus.org). Shaded boxes depict residues that are identical between the vaccinia I3 protein and at least eight other I3 homologs. The blue circles highlight
aromatic and basic residues that we hypothesize to correspond to a conserved DNA binding signature conserved in many SSBs; red lines depict clustered
charge-to-alanine mutants generated.
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than the WT I3 allele, either DNA sequencing or allele-specific PCR was
performed. Plaques of the appropriate genomic structure were subjected
to sequential rounds of plaque purification until all (20) progeny
plaques lackedNeo and contained only themutant I3 allele. These plaques
were expanded, and viral stocks were prepared. Formutants 4, 5 and 7, we
observed that all plaques that had undergone recombinational resolution
and had lost Neo (20 of which were isolated from each of two indepen-
dent Neo-positive intermediate viruses) retained the WT I3 allele,
whereas none retained the mutant I3 allele. Therefore, we concluded that
these three mutant alleles of I3 were unable to support virus viability.
Determination of 24-h viral yield. BSC40 cells in 35-mm dishes were
infected at an MOI of 2 and maintained at 31.5°C or 39.7°C. Cells were
harvested at 24 hpi, collected by centrifugation, and resuspended in 1mM
Tris (pH 9.0). The cells were disrupted by three cycles of freeze-thawing
and two 15-s bursts of sonication. Viral yields were assessed in plaque
assays performed on BSC40 cells at 31.5°C. Several independent experi-
ments were performed; for each experiment, viral yield was titrated in
duplicate, and the data were averaged and plotted with the standard de-
viations shown (see Fig. 5B).
In vitro transcription/translation of 3FLAG-I3 and His6-I3. The
TnT system from Promega was employed for in vitro transcription and
translation (IVTT) reactions. Fifty-microliter reactionmixtureswere pro-
grammed according to the manufacturer’s instructions using either 750
ng of one of the pET14b-His6-I3 plasmids or 250 ng of one of the pTM1-
3FLAG-I3 plasmids. The reaction mixtures were incubated for 90 min
at 30°C in the presence of 20 Ci of [35S]methionine. One-tenth of each
reaction mixture was saved for analysis as input, and the remainder was
mixedwith other reactionmixtures as appropriate and incubated at room
temperature for 1 h with gentle mixing.
The 3FLAG-I3 and any associated His6-I3 proteins were retrieved
using EZview Red anti-FLAG M2 affinity gel beads. The M2 affinity gel
beadswere added to the reactionmixtures, alongwith 300l of FLAG lysis
buffer (50 mM Tris [pH 7.4], 150 mM NaCl, 1% Triton X-100, 1 mM
EDTA, 1 g/ml leupeptin, 1 g/ml pepstatin, and 1 mM phenylmethyl-
sulfonyl fluoride [PMSF]), and the samples were incubated with end-
over-end rotation for 3 h at 4°C. Beads were retrieved by centrifugation
for 30 s at 10,400 g. The beads were washed twice in FLAG-TBS (50mM
Tris [pH 7.4], 150 mM NaCl), and bound proteins were eluted by the
addition of FLAG-TBS containing 15 g of 3FLAG-peptide (Sigma-
Aldrich, St. Louis, MO) for 30min on ice with gentle agitation. The beads
were collected via sedimentation, and the eluate was collected for analysis.
Radiolabeled proteins were resolved by SDS-PAGE and visualized by au-
toradiography. Quantitation was performed using a PhosphorImager
Storm Scanner and ImageQuant software.
Induction andpurification of recombinantHis6-I3.pET14b-His6-I3
constructs were transformed into the HMS174 strain of Escherichia coli.
Cultures were grown in the presence of 0.2% maltose, and I3 expression
was induced by infection with bacteriophage CE6 (MOI of 10), which
encodes T7 RNA polymerase. Induction was performed for 3 h (30min at
37°C and 2.5 h at room temperature), after which bacteria were collected
by sedimentation and lysed in 10 ml of pET lysis buffer (20 mM Tris [pH
8.0], 500 mMNaCl, 20 mM imidazole, 0.1% Triton X-100, 10% glycerol,
5 mg/ml lysozyme, 1 g/ml leupeptin, 1 g/ml pepstatin, and 1 mM
PMSF) and incubated on ice for 30 min. Lysates were sonicated twice for
15 s and clarified by centrifugation at 17,211 g for 30min. Recombinant
His6-I3 protein was purified by affinity chromatography using a HisTrap
FF column and an AKTA fast protein liquid chromatography (FPLC)
system (GE Healthcare Life Sciences, Piscataway, NJ). The column was
washed and developed with buffer (20 mM Tris [pH 8.0], 500 mMNaCl,
20mM imidazole, 0.1% Triton X-100, 10% glycerol, 1g/ml leupeptin, 1
g/ml pepstatin, and 1 mM PMSF) containing increasing concentrations
of imidazole. The peak of His6-I3 eluted at 250 mM imidazole; pooled
fractions were dialyzed against a buffer containing 50 mM Tris (pH 7.4),
250 mM NaCl, 1 mM EDTA, 10 mM -mercaptoethanol, and 25% glyc-
erol and stored at 80°C. Purifications were performed from 100- to
500-ml cultures.
Electromobility shift assays (EMSAs). The 24-mer oligonucleotide
probe (5=-CGTGTCGCCCTTATTCCGATAGTG-3=) was radiolabeled at
its 5= terminus with [-32P]ATP and T4 polynucleotide kinase. Thirty or
ninety nanograms of each I3 preparation was incubated with 2.4 pmol of
radiolabeled probe for 15 min at 30°C in a 15-l reaction mixture con-
taining 250 g of bovine serum albumin (BSA) per ml, 20 mM Tris (pH
7.4), 50 mMNaCl, 1 mMEDTA, and 5% glycerol. The samples were then
resolved electrophoretically on 15-cm vertical, nondenaturing 10% poly-
acrylamide gels which were cast and run in 0.25 Tris borate-EDTA
(TBE) (final concentrations of 22.25 mM Tris, 22.25 mM boric acid, 0.5
mM EDTA); electrophoresis was performed at 200 V for 4 h at 4°C. Gels
were dried and exposed for autoradiography. Bandswere quantified using
a PhosphorImager Storm Scanner and ImageQuant software.
Gel filtration analysis of recombinant I3.A total of 250g of purified
recombinant His6-I3 protein and 100 g each of individual gel filtration
standards (Bio-Rad, Hercules, CA) (thyroglobulin [670,000 Da], gamma
globulin [158,000 Da], ovalbumin [44,000 Da], and myoglobin [17,000
Da]) were mixed together and adjusted to contain 50 mM Tris (pH 7.4),
150 mM NaCl, 1 mM EDTA, 10 mM -mercaptoethanol, and 10% glyc-
erol. The sample was injected onto a HiPrep 16/60 Sephacryl S-100 High
Resolution column (GE Healthcare Life Sciences) that was equilibrated
and then developed in the same buffer. Chromatography was performed
at 0.45 ml/min on an AKTA FPLC apparatus at 10°C. One-milliliter frac-
tions were collected, and the elution profile of I3 was determined by SDS-
PAGE, followed by silver stain and immunoblot analysis.
siRNA-mediated interference.Twenty-one-nucleotide (nt) RNA du-
plexes (each strand possessing a terminal 3= dT dinucleotide) were pur-
chased from Dharmacon RNAi Technologies. siRNA sequences can be
found in Table S1 in the supplemental material. Each siRNA duplex (20
nM)was transfected into BSC40 cells that had been seeded the day prior at
a density of 2.25 105 cells/35-mmdish, usingTransIT-TKO transfection
reagent (Mirus Bio LLC, Madison, WI) as directed per manufacturer
specifications. At 18 h posttransfection, cells were infected withWT virus
(MOI of 3) and harvested at the time points indicated (see Fig. 6).
Immunoblot analysis of viral proteins.Whole-cell extracts were pre-
pared from siRNA-treated, virally infected cells, resolved on SDS–15%
acrylamide gels, and transferred electrophoretically to nitrocellulose fil-
ters. The blots were analyzed by incubation with polyclonal serum di-
rected against A20, I3, or F18 (29, 40, 42), followed by a horseradish
peroxidase-conjugated secondary antiserum (Bio-Rad). After develop-
ment with chemiluminescent Super Signal WestPico reagents (Pierce,
Rockford, IL), immunoreactive proteins were visualized on Kodak MR
film or captured by exposure on a FluorChem HD2 documentation sys-
tem (ProteinSimple, Santa Clara, CA) and quantified using AlphaView
software (ProteinSimple).
Southern dot blot hybridization to assess viral DNA accumulation.
Infected andmock- or siRNA-treated cells were harvested at the indicated
time points (3, 6, 8, 10, 12, and 18 hpi) and subjected to Southern dot blot
analysis as previously described (51). DNA was applied to Zeta Probe
nitrocellulose (Bio-Rad) and detected using a radiolabeled probe repre-
senting the HindIII E and F fragments of the vaccinia virus genome; the
bound probe was visualized by autoradiography and quantified on a
PhosphorImager Storm Scanner using ImageQuant software. Each sam-
ple was spotted in quadruplicate, and the data were averaged and plotted
with standard deviations shown.
Pulsed-field gel electrophoresis (PFGE). BSC40 cells were seeded at
2.25 105 cells per 35-mm dish 1 day prior to being pretreated with
siRNA (an siRNA directed against the I3 mRNA or a variant containing
4-nt substitutions predicted to cause mismatches [si-I3 or MM, respec-
tively]) as described above. After 18 h, cells were infected with WT virus
(MOI of 3) and harvested at 8 and 12 hpi. A fraction of the cells was
reserved for immunoblot analysis. Cell pellets were embedded in 0.5%
low-melting-point agarose and digested for 24 h at 50°C with mild agita-
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tion in 500 l of ESP buffer (1% Sarcosyl, 0.5 M EDTA [pH 9.0], 0.5
mg/ml proteinase K). The plugs were equilibrated in 0.5 TBE buffer
prior to insertion into premolded wells of a 1% SeaKem Gold agarose gel
cast and run in the same buffer. The DNA was resolved on a CHEFMap-
per XA apparatus (Bio-Rad) at 6 V/cm for 13 h at 14°C, using a switching
time gradient of 1 to 25 s, a linear ramping factor, and a 120° angle. The
DNA was visualized by ethidium bromide staining, and the image was
captured and quantified using AlphaView software (ProteinSimple). This
program allowed resolution of DNA species ranging from500 kb to5
kb. To resolve fragments from 200 kb to200 bp, duplicate samples were
resolved on the same type of gel at the same temperature using the follow-
ing parameters: 6 V/cm for 6 h, a switching time gradient of 0.05 s to 17.0
s, a ramping factor of a	 2.848 m, and a 120° angle.
Immunofluorescence microscopy. Infected and mock- or siRNA-
treated cells were incubated in the presence of bromodeoxyuridine
(BrdU) at a final concentration of 25g/ml. At 7 hpi, cells were fixed with
4% paraformaldehyde and permeabilized with 0.1% Triton X-100 for 5
min on ice. Samples were then stained with monoclonal anti-BrdU (5
g/ml; Developmental Studies Hybridoma Bank, University of Iowa,
Iowa City, IA) and polyclonal anti-I3 (1:400) antibodies followed by sec-
ondary antibodies conjugated to either Alexa Fluor 594 (goat anti-mouse
IgG) or Alexa Fluor 488 (goat anti-rabbit IgG) (Invitrogen). For preper-
meabilization experiments, infected cells were placed on ice, briefly
treated with 0.1% Triton X-100 (30 s), washed, and then fixed and pro-
cessed as described above.
Immunoelectron microscopy. BSC40 cells were infected with WT
virus (MOI of 5) in the presence of BrdU (25g/ml, added after 30min of
adsorption) for 7 h and fixed in situ with 4% paraformaldehyde–0.1%
glutaraldehyde in phosphate-buffered saline (PBS) for 60 min at room
temperature. Cells were processed for immunoelectron microscopy and
embedded in Lowicryl K4M; grids were stained using either anti-BrdU,
anti-I3, or anti-protein disulfide isomerase ([PDI]monoclonal 1D3, Enzo
Life Sciences, Ann Arbor, MI) antibodies, followed by incubation with a
secondary antibody conjugated to 10-nm gold particles. Grids were post-
stained with uranyl acetate and examined on either a Hitachi H-600 or
JEOL JEM2100 electron microscope.
Generationof an I3-mCherry fusion construct.Togenerate the pInt-
I3-mCherry construct, the mCherry open reading frame was amplified
from the pRSET-mCherry vector (46) using the mCherry 5= and 3= prim-
ers detailed in Table S1 in the supplemental material. The PCR product
was digested with BglII and positioned behind the vaccinia virus G8 pro-
moter in the pInt vector (52) that had been digested with BamHI and
treated with CIP. The I3 open reading frame lacking a termination codon
(amplified from WT genome; using the Cloning U and I3 no stop 3=
primers) (see Table S1 in the supplementalmaterial) was placed upstream
of the mCherry sequence via a unique BamHI site that had been placed
immediately upstream of the mCherry coding sequence (mCherry 5=
primer). The sequence of the pInt-I3-mCherry construct was confirmed
by restriction enzyme digestion and automated DNA sequencing.
Preparation of digital figures. Original data were scanned on an Ep-
son Perfection scanner (Long Beach, CA) and were adjusted with Adobe
Photoshop software (Adobe Systems, Inc., San Jose, CA). Data from
EMSAs, and TnTs were acquired on a Storm PhosphorImager (Molecular
Dynamics, Sunnyvale, CA) and quantified using ImageQuant software
(Molecular Dynamics). Images from immunoblot analysis were acquired
using the FluorChemHD2 documentation system (ProteinSimple, Santa
Clara, CA). The sequence alignments were performed by using the Clustal
Wmethod and Lasergene software (DNASTAR, Inc.,Madison,WI) using
sequences retrieved from the Poxvirus Bioinformatics Resource Center
(http://www.poxvirus.org). Statistical analysis and graph preparation
were performed using SigmaPlot software (Systat Software, Chicago, IL).
Final figures were assembled and labeled with Canvas software (Deneba
Systems, Miami, FL).
RESULTS
The vaccinia virus I3 protein has all of the functional hallmarks of
a replicative SSB. It is presumed to play an essential role during
infection since attempts to isolate a virus carrying an I3 deletion
have been unsuccessful (42). An alignment of the I3 orthologs
encoded by closely related (vaccinia, variola, monkeypox, camel-
pox, cowpox, and ectromelia viruses) and more divergent (myx-
oma, swinepox, lumpy skin disease, sheeppox, and molluscum
contagiosum viruses) chordopoxviruses is shown in Fig. 1. Resi-
dues that are shared by the vaccinia I3 protein and at least eight
other orthologs are shaded and boxed. Although SSBs from di-
verse organisms often share a structural feature known as an OB
(oligonucleotide/oligosaccharide-binding) fold (36, 49), there is
no primary sequence consensus associated with their affinity for
single-stranded DNA. A loosely conserved pattern of aromatic
and basic residues within the putative DNA binding domain of
various SSBs has been identified (55), and candidate residues for
such a signature within I3 are shown with blue circles in Fig. 1.
Forward genetic analysis of the I3 protein has been lacking
since neither the Condit or Dales collections of temperature-sen-
sitive (ts) viruses contain mutants with lesions in the I3 gene (22).
With the goal of generating a conditionally lethal mutant, we uti-
lized clustered charge-to-alanine mutagenesis to generate 10 vari-
ants of I3 (8, 16–18, 21, 40). The rationale behind this approach is
that clusters of charged residues are likely to be exposed on the
surface of a given protein, and hence their alterationmay compro-
mise protein-protein or protein-DNA interactions without dis-
rupting the overall folding and stability of the target protein. The
10 clusters of charged residues chosen for mutagenesis span the
protein sequence and are numbered and marked by red lines in
Fig. 1. Some of these clusters are highly conserved in all of the I3
homologs, whereas others are conserved only within the highly
related orthopoxviruses. The variant alleles were generated using
overlap PCR and then cloned into expression vectors for analysis
in vitro and in vivo.
Clustered charge-to-alanine mutagenesis of the I3 protein:
analysis of I3-I3 interaction in vitro.We reported some years ago
that recombinant I3 was predominantly monomeric in solution.
Its elution from a Superdex 75 gel filtration columnwas indicative
of a protein with a Stokes radius of 24.7 Å, which was extrapolated
to an apparent molecular weight (MW) of 34,000 (assuming I3 is
a globular protein) (42). However, many SSBs function as multi-
mers (27, 39, 41), and since our initial report, an I3-I3 interaction
was identified definitively in a global yeast two-hybrid screen of
the vaccinia virus proteome (32). The two-hybrid interaction has
been verified in our own lab (data not shown); we have also de-
veloped an in vitro assay to monitor the self-interaction of I3. The
WT and mutant alleles of I3 were each inserted into both the
pTM1-3FLAG and pET14b vectors, facilitating T7 RNA-poly-
merase driven expression of 3FLAG-I3 and His6-I3, respec-
tively. These two forms of I3 have distinct electrophoretic mobil-
ities. The proteins were expressed in vitro using the TnT coupled
transcription/translation system, mixed appropriately, and sub-
jected to affinity purification on anti-FLAG resin. The levels of
His6-I3 which copurified with the cognate 3FLAG-I3 were visu-
alized by autoradiographic analysis of electrophoretically resolved
proteins. The data (n 	 5) were quantified by phosphorimager
analysis after taking into account the individual levels of expres-
sion and were normalized to the retrieval obtained with the WT
Greseth et al.
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proteins (Fig. 2A). The efficiency of the I3-I3 interaction was
within 50% of the value obtained for the WT proteins for most of
the mutants. The I3-2 protein showed a modest but significant
(P
 0.05) increase in self-interaction efficiency above that level,
and the I3-8 protein showed a more substantial and significant
increase in the efficiency of self-interaction (P
 0.02). Most im-
portantly, the I3-4, -5, and -7 proteins showed a statistically sig-
nificant decrease in (or near ablation of) their ability to self-inter-
act (for I3-4, P
 0.05; for I3-5 and -7, P
 0.02).
Additional experiments were performed to test the hypothesis
that mutants 4, 5, and 7 had a specific defect in self-interaction
rather than exhibiting global misfolding (Fig. 2B). First, each of
the three mutant proteins was tested for its ability to interact with
WT I3 using the same protocol described above. As shown in Fig.
2B, the three His6-I3 mutant proteins retained the ability to inter-
act withWT 3FLAG-I3 (Fig. 2B, lanes 3, 7, and 11). For the I3-4
and -7 proteins, the efficiency of this interaction was comparable
to the self-interaction of the WT protein (Fig. 2B, lane 2). For the
I3-5 protein, a modest but statistically significant diminution in
interaction was observed (P
 0.02) (Fig. 2B, lane 7). These data
argue against a gross misfolding of the I3-4, -5, and -7 proteins. In
contrast, thesemutant proteins showed little to no ability to inter-
actwith themselves orwith each other (Fig. 2B, lanes 4 to 6, 8 to 10,
and 12 to 14). These data suggest that the three mutations, which
map relatively close to each other in the primary sequence of I3,
might affect a common binding pocket.
To gain further insight into the multimerization properties of
I3, we performed gel filtration analysis of purified preparations of
recombinant His6-I3 protein which were produced in E. coli and
purified bymetal ion affinity chromatography. A total of 250g of
His6-WT I3 protein was mixed with protein standards and re-
solved on a HiPrep 16/60 Sephacryl S100 column. The elution
profile showed two distinct peaks of protein (Fig. 3A). The elution
profile of the major peak was similar to that of ovalbumin, which
has a nativemolecular weight (MW)of 44,000 (fractions 46 to 49).
We interpret this peak as representative of monomeric His6-I3
(predicted MW of 32,000). An additional peak of protein had an
elution profile that overlapped with the thyroglobulin (670 kDa)
and immunoglobulin standards (158 kDa), which would be con-
sistent with a higher-order form of I3 that was at least tetrameric
(fractions 33 to 36). A similar analysis was performed with puri-
fied preparations ofmutants 4, 5, and 7. For each of these proteins,
only a single peak of I3 was observed: a comparison of fractions 33
to 36 and 46 to 49 from theWT, I3-4, -5, and -7 is shown in Fig. 3B.
In each case, I3 was abundant in fractions 46 to 49, but the higher-
order species of I3 (fractions 33 to 36) seen for theWTproteinwas
not seen with any of the three mutants. Taken together, the IVTT
and gel filtration data strongly suggest that a portion of WT I3
forms multimers in solution, whereas mutants 4, 5, and 7 are
deficient in this process.
Clustered charge-to-alanine mutagenesis of the I3 protein:
analysis of ssDNAbinding in vitro.Wehave previously described
the ssDNA binding activity of recombinant (and endogenous)
WT I3 using an EMSA (42).Wehave now extended this analysis to
His6-tagged versions of the WT and mutant I3 proteins. Each
affinity-purified recombinant His6-I3 protein preparation was
tested at 30 and 90 ng for its ability to bind a 5=-labeled 24-nt
oligonucleotide in an EMSA; a representative autoradiograph
(panel A) as well as quantification of replicate experiments (n	 4)
(panel B) are shown in Fig. 4. Although there was some variability
among the DNA binding properties of the different preparations,
only two mutants (I3-5 and -6) showed a statistically significant
(P 
 0.02) reduction in DNA binding activity at both protein
concentrations. The I3-6 protein was only modestly impaired and
exhibited 64 and 56% of the DNA binding activity of the WT
FIG 2 Analysis of I3-I3 self-interaction in vitro. Differentially tagged I3 pro-
teins were synthesized in IVTTs, affinity purified, and visualized by autora-
diography. (A) Quantification of I3-I3 self-interaction. Values are expressed
relative to WT-WT interaction (set to 1) and account for input for each reac-
tion. The gray bars represent statistically significant differences from the
WT-WT interaction (n 	 5; *, P 
 0.05; **, P 
 0.02). (B) Additional IVTT
reactions were performed characterizing the ability of the defective I3 proteins
(shown in panel A) to interact withWT I3 and each other. In the representative
autoradiograph shown, the migration of His6-I3 and 3FLAG-I3 is repre-
sented by the circle and diamond, respectively. Quantification of the I3-I3
self-interactions was performed using the same analysis as described for panel
A (n	 6; **, P
 0.02).
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protein at 30 and 90 ng, respectively. The reductionwas greater for
the I3-5 protein; the DNA binding activity of this protein ranged
from 10 to 37% of the WT protein as assayed at 30 and 90 ng,
respectively. Thus, the I3-5 protein is diminished both in its ca-
pacity to bind DNA and to self-interact. In contrast, the DNA
binding activities of mutants 4 and 7 do not appear to be dimin-
ished, despite their reduced ability to multimerize. Conversely,
mutant 6 shows a modest diminution in DNA-binding activity
without any obvious impairment in self-interaction. Cumula-
tively, these data indicate that the binding of I3 to a 24-mer oligo-
nucleotide in vitro does not require oligomerization. Further-
more, it is striking that all of the defects observed in the in vitro
biochemical assays were found in the proteins encoded bymutant
alleles 4 to 7, underscoring the importance of this region of the
protein in the function of I3.
Clustered charge-to-alanine mutagenesis of the I3 protein:
generation of viral recombinants with altered I3 alleles in an
attempt to generate a temperature-sensitive virus.Although the
I3 protein is presumed to be the replicative SSB, direct genetic
proof of such a role has been lacking. Therefore, the same 10
clustered charge-to-alanine mutants were cloned into an appro-
priate vector (pUC-Neo) (29) such that transient dominant selec-
tion could be used to insert them in place of the endogenous I3
allele within the viral genome. All of the manipulations aimed at
isolating these viruses were performed at 31.5°C to ensure the
viability of any viruses with temperature-sensitive (ts) pheno-
types, since tsmutants with defects in the vaccinia virus A20, H5,
G2, and D1 proteins have been readily obtained using this ap-
proach (8, 16–18, 21, 40). Viruses encoding the I3-1, -2, -3, -6, -8,
-9, and -10 proteins were readily obtained, extensively plaque pu-
rified, and expanded. As shown in Fig. 5A, the plaques formed by
these viruses at both 31.5°C and 39.7°Cwere comparable in size to
those formed by WT virus at these temperatures. Likewise, the
viral yields obtained after cells were infected for 24 h with each of
the viruses at an MOI of 2 were generally equivalent at both tem-
peratures and equivalent to the yield fromWT-infected cells (Fig.
5B). A modest decrease in yield was seen at both temperatures for
the virus encoding I3-2, but it is unclear whether this difference is
of any biological significance. Hence, alleles 1, 2, 3, 6, 8, 9, and 10
were competent to support virus viability in a temperature-insen-
sitive manner. In contrast to these results, we were unable to ob-
tain viruses encoding only the I3-4, -5, or -7 allele despite repeated
and concerted efforts. The transient dominant technique involves
the isolation of intermediate viruses that, in this case, have tandem
duplications of portions of the I2-I3 or I3-I4 region of the genome
flanking the Neo gene. This insertion/duplication allows for selec-
tion of G418-resistant (G418r) plaques. After the intermediate vi-
ruses are isolated, G418 selection is removed, and the duplication
is resolved by homologous recombination between the tandem
repeats. We had no difficulty isolating these intermediate viruses
FIG 3 Gel filtration analysis of themultimeric state of I3. (A) A total of 250g of purifiedHis6-WT I3 was combined with 100g each of thyroglobulin (670,000
Da), immunoglobulin (158,000 Da), ovalbumin (44,000 Da), and myoglobin (17,000 Da) and resolved on a HiPrep 16/60 Sephacryl S100 high-resolution
column. Fractionswere collected, and fractions 31 to 53were resolvedby SDS-PAGEandvisualizedby silver staining. Thyroglobulin, immunoglobulin, ovalbumin, and
His6-WT I3 are represented by diamonds, circles, brackets, and arrowheads, respectively. A total of 250 ng of purifiedHis6-WT I3 was loaded in the input lane to show
the migration of I3. Dashed boxes represent fractions used for further comparative analysis with I3 mutant proteins. (B) Gel filtration analysis was performed on
affinity-purified recombinantHis6-I3, -4, -5, and -7proteins in a similarmanner asHis6-WTI3. Identical fractions (33 to 36 and46 to49)were subjected to comparative
analysis by silver staining. Arrowheads show the position of I3; theMW standards (in thousands) are labeled as described for panel A.
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after transfection of the plasmids encoding the I3-4, -5, or -7 allele,
but in each case, all of the resolved viruses retained the WT, and
not the mutant, allele. Therefore, we feel confident in concluding
that these three mutant alleles are not competent to support virus
viability. Interestingly, the three mutants that could not support
virus viability are the same three that were defective in self-inter-
action (Fig. 2); moreover, I3-5 was also defective in DNA binding
(Fig. 4). These data suggest that the ability of I3 to form higher-
order complexes is likely to play a biologically important role dur-
ing the infectious cycle.
siRNA-mediated depletion of I3 leads to a diminution in vi-
ral DNA replication and 24-h viral yield.Our inability to gener-
ate viruses encoding only I3-4, -5, or -7 provided strong evidence
that I3 is indeed an essential viral protein. We were not, however,
successful in isolating a tsI3 virus. As an alternative approach, we
generated an siRNAdirected against the I3mRNA(si-I3) aswell as
a variant containing 4-nt substitutions predicted to cause mis-
matches and eliminate stable targeting (MM) (sequences can be
found in Table S1 in the supplemental material). Our most effec-
tive siRNA targeted nucleotides 274 to 292 of the ORF, just down-
stream of the siRNA previously reported by Gammon and Evans
(nt 236 to 256) (14). (An additional oligonucleotide duplex tar-
geting nt 551 to 571wasmuch less effective in depleting I3 andwas
not investigated further.) To assess the impact of the siRNAon the
steady-state levels of the I3 protein and on viral DNA accumula-
tion on a cell-by-cell basis, cells were infected for 7 h in the pres-
ence of BrdU. The incorporation of BrdU into nascent DNA and
the levels of I3were then assessed by immunofluorescencemicros-
copy (42, 51). In mock-treated cells or cells exposed to the MM
siRNA (data not shown), we readily observed the presence of large
replication foci in which the I3 protein and nascent DNA were
colocalized (Fig. 6A, left panels). In cells treated with siRNA di-
rected against I3, the sizes of the I3-positive (I3) and BrdU foci
were dramatically and comparably decreased (Fig. 6A, right pan-
els). Hence, the siRNA was effective in depleting I3, which in turn
led to a corresponding decrease in DNA synthesis. More quanti-
tative assessments of the depletion of I3 and the levels of DNA
synthesis can be obtained from immunoblot and dot blot hybrid-
ization analyses, respectively (Fig. 6B and C). The siRNA treat-
ment diminished the levels of I3 to approximately 8 to 10% of
those seen in cells treated with MM siRNA (Fig. 6B). This deple-
tion was specific since the levels of other early replication proteins
such as UDG (data not shown) and A20 were not impacted. Dot
blot hybridization analysis indicated that I3 depletion reduced the
accumulation of viral DNA sequences by 4-fold at the time
points studied (Fig. 6C). This reproducible reduction in DNA
accumulation is statistically significant (P 
 0.02 at 6 and 8 hpi;
P
 0.001 at 10, 12, and 18 hpi) but incomplete, and the accumu-
lation of postreplicative proteins such as F18 (57) is not impaired
(Fig. 6B, bottom blot). The 24 h yield of infectious virus under
these same conditions was consistently diminished by 3.3-fold
(P
 0.02) (Fig. 6D). These data suggest that either I3 is present in
FIG 4 DNA binding analysis of the mutant I3 proteins. (A) EMSAs were performed containing 2.4 pmol of radiolabeled ssDNA oligonucleotide and purified
recombinantHis6-I3. Reactions were resolved electrophoretically, and a representative gel is shown. For theWT and I3mutant preparations, the first and second
lanes represent reaction mixtures containing 30 and 90 ng, respectively. The upper band (labeled B) represents ssDNA probe bound to the I3 protein, while the
lower band (labeled F) represents the free ssDNA probe. The left-most lane of the blot (—) represent ssDNA probe in the absence of added recombinant protein.
(B) Quantification of I3 binding to ssDNA (depicted in panel A). Values are expressed as the ratio of bound probe to bound probe plus free probe: (B/B F)
100. Dashed lines represent values obtained for purified WT I3. **, P
 0.02.
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excess of what is needed to support DNA synthesis (10- to 12.5-
fold reduction of I3 leads to an4-fold reduction in DNA accu-
mulation) or that I3 plays a stimulatory but not essential role in
DNA synthesis.
To gain further insight into how I3 depletionmight affectDNA
accumulation, we performed pulsed-field gel electrophoresis
(PFGE) to assess the DNA species present at 8 and 12 hpi in cells
treatedwithMMor si-I3 and then infectedwithWTvirus (MOIof
3) (Fig. 6E). There was a clear diminution (3- to 7-fold) in the
levels of the mature, monomeric genome (200 kb) (Fig. 6E,
arrowhead) in cells treated with si-I3. We did not, however, see
any evidence of unresolved concatemeric DNA, which would mi-
grate more slowly than mature genomes, nor did we observe the
reproducible accumulation of subgenomic species; in addition to
the PFGE gel shown in Fig. 6, samples were analyzed under other
electrophoretic conditions that allowed visualization of DNA as
small as 200 bp (not shown).
Intracellular localization of I3: insight into the organization
and structure of these factories. As shown in Fig. 6A and previ-
ously (42), I3 localizes to discrete foci within infected cells that are
termed replication factories. The specificity of this localization is
illustrated in Fig. 7A: whereas an I3-mCherry fusion protein lo-
calizes to discrete replication factories, the mCherry protein itself
is dispersed throughout the cytoplasm. To test the hypothesis that
the localization of I3 reflects its association with stable structures
that might contain scaffolding proteins, cytoskeletal elements, or
DNA-containing complexes, we assessed the retention or loss of I3
when cells were briefly prepermeabilizedwith TritonX-100 (0.1%
for 30 s) prior to fixation for immunofluorescence analysis. Com-
parable protocols have been shown to release soluble proteins
from the cytosol or nucleoplasm but not those anchored by asso-
ciation with the cytoskeleton or the nuclear matrix (4, 19, 28, 37).
The diffuse pool of I3 (along with other cytosolic proteins) is lost
during this prepermeabilization step, but the factory-associated I3
is anchored and is not diminished during prepermeabilization
(Fig. 7B).
To obtain a higher resolution view of the BrdU, I3 replica-
tion factories shown in Fig. 6A, cells were harvested at 7 hpi (MOI
of 2 in the presence of BrdU) for examination by conventional and
immunoelectron microscopy. The most striking features seen
were organelle-free zoneswithin the cytoplasm (Fig. 7C) that were
filled with material of even electron density (RF; replication fac-
tories) and appeared to be surrounded by doublemembranes (red
arrowheads). Immunoelectron microscopy indicated that these
delimiting membranes (Fig. 7D, red arrowheads) were labeled by
an antibody to protein disulfide isomerase (PDI), a marker of the
endoplasmic reticulum (ER) (Fig. 7D, red asterisks). The interior
of the zones was labeled at high density with antibodies to BrdU
(Fig. 7E, cyan asterisks), consistent with these zones being repli-
cation factories in which nascent DNA was being synthesized.
These data reinforce the proposal (50, 56) that the replication of
the poxvirus genome occurs within specialized, membrane-de-
limited cytoplasmic compartments.
DISCUSSION
The cytoplasmic localization of the poxviral life cycle necessitates
that the virus encodesmost, if not all, of its replicationmachinery.
The poxvirus machinery must overcome the universal problems
presented by the need to replicate a double-stranded DNA tem-
plate, as well as solving the somewhat unique problems presented
by replication within the cytoplasm, such as evading cytoplasmic
DNA sensors (58). To compartmentalize replication and concen-
trate the precursors, enzymes, and template, poxviruses appear to
induce the formation of membrane-delimited paddocks that are
dedicated sites of replication (Fig. 7). These paddocks have been
noted before and are referred to as “mininuclei” (50, 56). The I3
SSB described in the manuscript localizes to these sites of viral
replication, which are the sites of accumulation of BrdU-labeled
nascent DNA (Fig. 7). The paddocks appear to be delimited by
PDI-positive (PDI) membranes derived from the ER, and it will
be of interest in the future to understand how the ER membranes
are recruited to enclose and shape these replication foci. Efficient
replication in the cytoplasm may also provide the underlying ra-
tionale for why poxviruses encode such precursor-generating en-
zymes as ribonucleotide reductase (RR). An early report suggested
that the viral ribonucleotide reductase interacted directly with the
I3 protein (6), providing a mechanism whereby precursors might
be synthesized at the site of utilization. Interestingly, it was the
acidic C= terminus of I3 that was shown to bind to the small sub-
unit of the ribonucleotide reductase. Many SSBs have an acidic C
FIG 5 Analysis of I3 viral recombinants in vivo. Recombinant viruses were
generated using transient dominant selection such that the endogenous I3
allele was replaced with one of the 10 clustered charge-to-alanine mutants
described above. Viruses encoding seven of these alleles were readily purified.
(A) Plaque assays were performed at both 31.5°C and 39.7°C (permissive and
nonpermissive temperatures, respectively), and results were visualized by crys-
tal violet staining after 48 h of infection. (B) At 24 h, viral yield was assessed
utilizing these recombinant viruses at both permissive (black bars) and non-
permissive (gray bars) temperatures.
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FIG 6 siRNA-mediated depletion of I3 during viral infection. (A) Immunofluorescencemicroscopy of nascent viral DNAdepots. Infected cells were eithermock
treated or preloaded with I3-directed siRNA (si-I3) and fixed at 7 hpi for immunofluorescence microscopy. I3 and BrdU foci colocalized, as visualized in the
merge panels, and their relative sizes decreased in the presence of I3-specific siRNA. (B) Immunoblot analysis of siRNA-treated infected cells. Whole-cell lysates
were probed for three viral proteins (A20, I3, and F18) to assess the specificity of the I3-directed siRNA. In triplicate, cells were preloaded with mismatch (MM)
or I3 siRNA and harvested at 6 or 18 hpi for immunoblot analysis. (C) Southern dot blot analysis to measure viral DNA sequences. siRNA-treated cells were
infected with WT virus, harvested at various times postinfection, and processed for Southern blot analysis. Viral sequences were detected using radiolabeled
vaccinia virus sequences, quantitated, and plotted. Samples were spotted in quadruplicate, and bars represent standard deviations. **, P
 0.02; ***, P
 0.001.
(D)Viral yield assessment. At 24 h viral yieldwas determined inWT-infected cells that had received eitherMMor I3-specific siRNA. **,P
 0.02. (E) Pulsed-field
gel electrophoresis analysis of the nascent viral genomes after siRNA-directed I3 depletion. BSC40 cells were pretreated with siRNA (MMor si-I3) for 18 h prior
to infection withWT virus (MOI of 3). At 8 and 12 hpi, cells were harvested and analyzed by PFGE as described inMaterials andMethods section; the DNAwas
visualized by ethidium bromide staining. The arrowhead denotes the migration of full-length monomeric genomes.
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terminus, and this region has been shown to coordinate interac-
tions with a plethora of core components of the replication appa-
ratus as well as auxiliary proteins involved in diverse aspects of
DNAmetabolism (20, 31, 48). I3 has very recently been shown to
bind to the cellular translation initiation factor eIF4G, which re-
localizes to viral factories after infection (60). The possibility that
the abundant I3 protein mediates the selective redistribution of a
host translation factor is an intriguing observation and an area for
future study.
Single-stranded DNA binding proteins (SSBs) are ubiquitous
components of all replicative systems studied to date, and there is
strong evidence that SSBs also play integral roles in DNA repair
and DNA recombination. I3 fulfills the properties of an SSB by
binding single-stranded DNA tightly and with great specificity
(42, 53). Although the primary sequences of SSBs are quite di-
verse, the majority have been shown to contain one or more OB
(oligonucleotide/oligosaccharide-binding) folds; this structural
domain is comprised of a five-stranded beta sheet coiled to form a
closed beta-barrel (36). We have utilized a variety of structural
prediction programs, such as PHYRE (23), Swiss Model (1, 24),
and i-Tasser (43, 44), to probe for conserved structural domains in
the I3 protein, to no avail. These modeling algorithms failed to
discern the presence of anyOB folds or other conserved structural
motifs within I3. Although structural prediction programs failed
to identify an OB fold in the herpes simplex virus (HSV)-encoded
SSB (ICP8), a region containing a similar set of ß-sheets and a
motif of aromatic and basic residues was identified in the solved
structure (30). The SSB from the bacterium Thermoproteus tenax
(38) lacks an OB fold and binds DNA through a unique sequence
that resides immediately upstream of a C-terminal multim-
erization domain. The DNA binding cleft of this SSB is also
lined with phenylalanine residues and flanked by basic resi-
dues. The adenovirus SSB lacks an OB fold, and its binding is
also mediated by a cleft containing key phenylalanine and basic
residues (54). A conserved pattern and spacing of aromatic and
basic residues were identified within the SSBs of E. coli, several
bacteriophages, and several herpesviruses (55), and we have
identified such a possible motif in the I3 protein (Fig. 1, blue
circles). It will be of interest in the future to determine whether
targeted mutagenesis of these residues impairs the interaction
of I3 with DNA; if so, we would expect that such alleles would
be unable to support virus viability. Of course, solution of the
FIG 7 Visualization of replication factories by electron and immunofluorescence microscopy. (A) Fluorescence microscopic visualization of I3-mCherry in
vaccinia virus-infected cells. Cells were infected with WT virus and transfected with plasmids encoding mCherry or I3-mCherry and visualized by fluorescence
microscopy at 7 hpi (594 nm). (B) Immunofluorescence microscopy showing retention of I3 within replication factories. Cells were infected with WT virus for
7 h and then either prepermeabilized with 0.1% Triton X-100 for 30 s prior to fixation (right panel) or fixed directly (left panel). Both sample sets were then
processed for immunofluorescence microscopy using the anti-I3 antibody. (C) Visualization of replication factories by electronmicroscopy. Cells were infected
with WT virus for 7 h and then examined by electron microscopy. RF, replication factories; Nu, nucleus; red arrowheads, double membranes surrounding and
penetrating the replication factories. (D and E) Immunoelectron microscopic examination of replication factories. Cells were infected with WT virus for 7 h in
the presence of BrdU and then processed for immunoelectron microscopy. Sections were probed with anti-PDI (D) or anti-BrdU (E) antibodies and a 10 nm
gold-labeled secondary antibody. Red arrowheads indicate doublemembranes that delimit the replication factories; red asterisks highlight their staining with the
anti-PDI antibody. Cyan asterisks indicate the heavy labeling of the interior of the replication factories with the anti-BrdU antibody.
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crystal structure of I3 would greatly illuminate the mechanism
by which it binds to ssDNA.
With the goal of gaining further insight into the contribution
of I3 to the replication, recombination, and repair of the vaccinia
virus genome, we utilized clustered charge-to-alanine mutagene-
sis to generate 10 mutant alleles of I3. Seven of these alleles were
able to support virus viability in vivo, and the viruses encoding
these alleles formed WT-sized plaques at both 31.5 and 39.7°C;
moreover, no defect in 24-h viral yield was seen during single-
cycle infections (Fig. 5). In contrast, we were unable to isolate
viruses in which the endogenous I3 locus expressed I3-4, -5, or -7,
despite repeated attempts. We believe that these alleles are unable
to support viral replication.
To investigate the ability of the proteins encoded by the 10
targeted alleles to multimerize, the mutant proteins and WT I3
were expressed in vitro using IVTT. Each of the mutant proteins
was able to interact with WT I3 in vitro, but the I3-4, -5, and -7
proteins were severely impaired in their ability to interact with
themselves or with each other (Fig. 2). We also expressed and
purified His6-tagged forms of WT I3 and each of the 10 mutant
proteins, and the multimerization defects of I3-4, -5, and -7 were
confirmedby gel filtration analysis (Fig. 3). These data suggest that
these amino acid substitutions, which span a 51-residue region of
the protein, may perturb the I3-I3 interaction interface. Interest-
ingly, these were the only three mutants that were unable to sup-
port virus viability in vivo. Additionally, as stated above, it has
been previously proposed that the acidic C-terminal 81 amino
acids (aa) of I3 can mediate an interaction with the small subunit
of the viral ribonucleotide reductase (RR) (6). The lesions within
the I3-5 and -7 alleles fall within this domain, and the subtle
changes introduced in these I3 proteins may be sufficient to dis-
rupt the I3-RR interaction andmay contribute to their inability to
support viral replication in vivo.
These purified preparations of His6-I3 were also examined for
DNA binding activity in vitro using EMSAs. The I3-6 protein
showed a modest decrease in DNA binding activity (Fig. 4), but a
virus encoding only I3-6 was not compromised in vivo (Fig. 5). In
vivo, a high local concentration of I3 may be sufficient to over-
come some reduction in intrinsic DNA binding activity. I3-5 was
more severely impaired in its ability to bind to ssDNA, and, as
mentioned above, it was unable to multimerize in vitro or to sup-
port viral replication in vivo. Although we have reported that the
interaction of I3 with ssDNA in vitro is not cooperative (42), mul-
timerizationmay play an important role in vivo. In fact, most SSBs
are known to function as multimers, and often self-interaction
juxtaposes the DNA-binding sites in a manner that stabilizes and
enhances DNA binding (27, 39, 41). Thus, even though I3-4 and
-7 can bind DNA oligonucleotides in vitro as assayed by EMSA,
their DNA binding activities may not be optimal or sufficient in
vivo.
Hence, while bothDNAbinding and the ability to formhigher-
order complexes appear to be important for the biological activity
of I3 in vivo, we do not believe that they are intrinsically linked.
Self-association of I3was verified by yeast two-hybrid analysis (32;
also data not shown), the interaction of 3FLAG-I3 and His6-I3
in vitro (Fig. 2), and gel filtration chromatography (Fig. 3). Our
data confirm that I3 forms higher-order complexes, but the deter-
mination of the precise stoichiometry of these complexes and the
impact of solution conditions and ssDNA on complex formation
are areas for future study. In addition to enhancing I3-DNA in-
teractions, multimerization of I3may also present a novel binding
surface for the recruitment of other viral proteins involved in rep-
lication, recombination, or repair.
We have previously reported that the I3 protein is phosphory-
lated during infection (42). Recombinant I3 and endogenous I3
exhibit comparable ssDNA binding properties (42, 53), signifying
that phosphorylation is not required for the I3-DNA interaction.
Moreover, the data presented here indicate that phosphorylation
is also not required for I3-I3 multimerization. However, the iden-
tification of the sites on which I3 is phosphorylated and the sub-
sequent determination of whether these modification events are
important in vivo will shed further light on how I3 contributes to
viral DNA metabolism.
By analogy to many other systems, it is reasonable to propose
that I3may play a significant role in DNA replication, recombina-
tion, and repair. A single-strand annealing (SSA) mechanism that
relies on the 3=-5= exonuclease activity of the viral polymerase has
been proposed for the high levels of homologous recombination
that occur during poxvirus infections (14). The I3 protein has
been shown to stimulate polymerase-mediated strand-joining in
vitro (59), and partial depletion of I3 (3- to 6.5-fold reduction) has
been shown to halve the frequency of recombination in vivo (14)
while reducing the levels of viral DNA replication by3-fold. Our
siRNA protocol has enabled us to reduce the levels of I3 by 10- to
20-fold (Fig. 6B), which leads to a 4- to 7-fold reduction in DNA
accumulation (Fig. 6C and E) and an 3.5-fold reduction in in-
fectious virus production (Fig. 6D).We were somewhat surprised
that the impact of I3 depletion on viral DNA synthesis was not
more drastic and postulate either that I3 is present in excess or that
it plays a stimulatory, but not essential, role in viral DNA replica-
tion. The latter conclusion seems unlikely, given our earlier inabil-
ity to isolate a virus in which the I3 locus has been deleted (42);
generation of an I3-expressing cell line that might support the
replication of a I3 virus would be another possible approach to
test the essentiality of I3. As a complement to the dot blot hybrid-
ization assay used to assess the levels of DNA synthesis (Fig. 6C)
(14), PFGE analysis (Fig. 6E) verified that depletion of I3 caused a
diminution in the levels of mature, monomeric genome that ac-
cumulated during infection. This diminution was not accompa-
nied by a concomitant increase in unresolved genomes or sub-
genomic fragments. These data suggest that replication is slow
and/or inefficient when I3 levels are low.
In sum, the cell biological, genetic, and biochemical data pre-
sented in this study expand our understanding of the vaccinia
virus-encoded I3 single-strandedDNA-binding protein. The eval-
uation of 10mutant alleles of I3 in vitro and in vivo and the assess-
ment of siRNA-mediated depletion of I3 in vivo provided the first
substantive genetic analysis of the contribution of I3 to viral rep-
lication. These data confirm that the ability of I3 tomultimerize is
associated with its ability to support viral replication in vivo and
identify a region of the protein whose perturbation impairs mul-
timerization. Further evaluation of the interaction of I3with other
proteins involved in DNA metabolism, a more thorough evalua-
tion of the mechanism by which I3 interacts with ssDNA, and an
assessment of how I3 is regulated by posttranslational modifica-
tion will be areas of interest for future study.
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TABLE S1 Primers used in this studya 
Upstream Primers (sense strand) Downstream Primers (antisense strand) 
Name Sequence Name Sequence 
U(1) GAGGATCCGAGTTATTCC D(1) GAGGATCCTTGTGCTTAATG 
U(2,3) GAGGATCCACCGGTGGTTTGTG D(2,3) GAGGATCCGTCCCAGATTACGAG
CC 
U(4-10) GAGGATCCGATAGAAGCGATGG
ATAC 
D(4-10) GAGGATCCATTTAAGTTCACC 
1C GGTAATCGCGGCGGCAGTTGAA
ACTTCACC 
1B TTCAACTGCCGCCGCGATTACCTT
ACTCATG 
2C TTAAGCACGCGGCAGCCATTCC
AAATTCTTTG 
2B TTGGAATGGCTGCCGCGTGCTTA
ATGTTTCCA 
3C AAACATTTGCGGCTGCATCCAT
CTTCATCAAC 
3B AGATGGATGCAGCCGCAAATGTTT
TCTCTGTA 
4C CACTCAGTGCAGCAGCAGCACA
ATTGGCCAAGGCA 
4B CCAATTGTGCTGCTGCTGCACTGA
GTGATTCTAGTTC 
5C GCACTCGCGGCACTAATCATTG
ATAG 
5B GATTAGTGCCGCGAGTGCGAATG
TAAT 
6C AATCATTGCTGCAGCAGTGGTG
GCTAACGTT 
6B CCACCACTGCTGCAGCAATGATTA
GTTTCTTG 
7C AGATAGTGCAGCTGTATCAATG
ACTGA 
7B TGATACAGCTGCACTATCTCCAGA
GA 
8C AATGTAGCAGCAGCTCTGGCTC
GTAATCTG 
8B GAGCCAGAGCTGCTGCTACATTTT
CAGTCA 
9C GATATTGCTGCTGCATATGATGA
AGATAG 
9B CATCATATGCAGCAGCAATATCAA
CAAGTC 
10C AGATAGCGCTGCAGCAGCGCCA
ATATTCAATG 
10B TATTGGCGCTGCTGCAGCGCTAT
CTTCATCAT 
Cloning 
 U 
GAGGATCCCATATGAGTAAGGT
AATC 
Cloning 
D 
GAGGATCCTTATACATTGAATATT
GGC 
Cloning 
Mutant 
U(1) 
GAGGATCCCATATGAGTAAGGT
AATCGCGGCGGCAGTTGAAAC 
Cloning 
Mutant 
D(10) 
GAGGATCCTTATACATTGAATATT
GGCGCTGCTGCAGCGCTATCTTC 
mCherry 
5’ 
GCAGATCTCATATGGGATCCGT
GAGCAAGGGCGAGG 
mCherry 
3’ 
GTAGATCTTCACTTGTACAGCTCG
TCC 
I3 no 
stop 3’ 
GAGGATCCTACATTGAATATTGGC 
I3-siRNA 
sense 
GAUAGAAGCGAUGGAUACUtt I3-siRNA 
antisense 
AGUAUCCAUCGCUUCUAUCtt 
MM-
siRNA 
sense 
GAUAGAACGGAUCCAUACUtt MM-
siRNA 
antisense 
AGUAUGGAUCCGUUCUAUCtt 
a All primers are written 5’→3’;restriction enzyme sites are bolded; the altered nucleotides are 
underlined; the initiating and terminating codons are double underlined. Those residues altered 
in the siRNA-I3 MM duplex are marked with strike-throughs. 
b For the U and D primers, the numbers in the parentheses designate the alleles for which each 
primer was used. 
U(x) + XB 
D(x) + XC 
